ArticleIranian journal of pharmaceutical research : IJPR

Cost-Utility Analysis of Erenumab Compared to Topiramate for Preventive Therapy of Migraine in Iran.

Hosein Mollaee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.